Stock data
Decoy Therapeutics Inc. (DCOY)
Decoy Therapeutics Inc. (DCOY) reported net income of -US$12.52M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$12.61M | -US$12.52M | — |
| 2024 | — | — | -US$5.73M | -US$5.58M | — |
| 2023 | — | — | -US$12.89M | -US$12.54M | — |
| 2022 | US$0.00M | — | -US$31.84M | -US$31.61M | — |
| 2021 | US$1.84M | — | -US$12.81M | -US$12.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.23M | -US$2.37M | — |
| 2026-03-31 | — | -US$2.22M | — |
| 2025-12-31 | — | -US$8.98M | — |
| 2025-09-30 | — | -US$0.87M | — |
| 2025-06-30 | US$0.00M | -US$0.96M | — |
| 2025-03-31 | — | -US$1.71M | — |
| 2024-12-31 | — | -US$1.46M | — |
| 2024-09-30 | — | -US$0.97M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.